magnolia medical appoints robert e gerberich chief commercial officer  magnolia medical toggle navigation recent news magnolia medical appoints robert e gerberich chief commercial officer april   download press release contact liz dowling dowling  dennis public relations tel  lizdowlingdennisnet magnolia medical appoints robert e gerberich as chief commercial officer new senior executive strengthens management team to accelerate commercialization of steripath blood collection system seattle april  – magnolia medical technologies today announced the appointment of robert e gerberich as its chief commercial officer mr gerberich will be responsible for leading all commercial and customer facing functions of the company magnolia medical is a leading medical device company that develops manufactures and markets steripath® and other proprietary blood and bodily fluid collection devices that significantly improve the accuracy consistency and predictability of critical invitro diagnostic ivd tests mr gerberich is a global business leader with over  years of experience in the surgical and medical device segments of the life sciences market as a senior sales and marketing executive he has an exceptional track record of success building new markets and driving rapid commercial growth from product introduction through broad scale adoption most recently mr gerberich served as vice president of sales and marketing and vice president of sales at invuity inc under his direct commercial leadership invuity transformed from a small distributordriven surgical lighting startup into a rapid growth direct salesdriven advanced surgical photonics company leading the advancement of open minimal access surgery at invuity mr gerberich led the company from a  million up to  million revenue run rate delivering  consecutive quarters of quarteroverquarter sales growth additionally he drove the creation launch and implementation of strategic marketing and partnership programs that effectively facilitated a topdown bottomup sales strategy the commercial impact of these programs supported the successful initial public offering of the company in june of  prior to invuity mr gerberich served as president of ultrashape north america and head of global sales for ultrashape ltd acquired by syneron medical ltd where he established the north american subsidiary for ultrashape and launched the first nonsurgical focused ultrasound body sculpting technology in the world in these roles gerberich led corporate global sales and distribution in over  countries before ultrashape mr gerberich was vice president of sales and marketing and vice president of sales for thermage inc now solta medical a division of valeant pharmaceuticals where he led the startup business and successful platform launch of a proprietary radiofrequency technology creating a new market for noninvasive tissue tightening he built a direct sales organization from the ground up and led the company from  to a  million revenue run rate earlier in his career gerberich led dynamic and fast growing sales organizations at several other medical device companies that developed products for hospital markets “we are thrilled to have bob join our senior management team and lead the overall commercial organization” said greg bullington ceo of magnolia medical “bob’s unique background and demonstrated expertise seeding and rapidly developing new product categories and markets within the medical device industry make him the perfect fit based on our stage of growth he is an outstanding leader with an exceptional track record of success” “i am very enthusiastic to be joining magnolia medical technologies” gerberich said “our proprietary steripath blood culture collection system addresses a significant unmet clinical need and will set the new standard of care for the prevention of blood culture contamination and ‘false positives’ throughout the world it is exciting to be with a company that has such a significant impact on improving patient care while yielding dramatic cost savings for the hospital and global healthcare markets” about blood culture contamination blood culture is the essential blood test used to diagnose sepsis a complication from bloodstream infection that claims over  us lives each year and is a leading cause of death with the current use of traditional collection methods an average of  percent to  percent of positive blood culture tests are contaminated and ultimately determined to be false positive that original misdiagnosis in turn often exposes patients to potent antibiotic treatments that may be inappropriate as well as unnecessary and typically extends hospital length of stay with longer patient stays there is an increase in both healthcare costs and the risk of hospitalacquired conditions about steripath the company’s proprietary flagship product steripath is the only blood collection system clinically proven to virtually eliminate the “preventable error” of blood culture contamination and “false positive” blood culture test results from patients with suspected sepsis the steripath blood collection system significantly reduces false positive results by diverting and sequestering the initial  milliliter of blood which can contain contaminants creating access for sterile blood flow into the culture test bottles the easy to use sterile singleuse closed system has been proven in multiple large scale clinical settings and trials to reduce false positive blood cultures by over  thereby reducing the unnecessary and inappropriate use of antibiotics and associated patient risks of developing antibioticresistant infections and complications and reduce the unnecessary costs and patient exposure to healthcareassociated infections hais associated with extended length of stay due to false positive culture results steripath facilitates immediate and measurable quality improvement for hospitals across the us that are implementing effective antimicrobial stewardship programs to reduce unnecessary and inappropriate use of antibiotics based on mandated requirements from the joint commission and cms about magnolia medical technologies magnolia medical is a medical device company that develops manufactures and markets innovative blood and bodily fluid collection devices that significantly improve the accuracy consistency and predictability of critical ivd tests false positive and false negative laboratory test results in the acute care setting create confusion and uncertainty that commonly lead to inappropriate unnecessary treatments these misdiagnoses often significantly increase utilization of antibiotics and associated complications as well as patient length of stay and risk for healthcareassociated infections hais by mechanically eliminating preventable errors that cause erroneous test results through elegantly engineered bodily fluid collection devices magnolia medical’s products significantly improve patient safety patient experience and reduce hospital costs the company has amassed an extensive ip portfolio protecting its products including  issued method apparatus and design patents with over  additional patent applications pending the total potential market for magnolia medical’s technology exceeds  billion annually for more information visit wwwmagnoliamedicalcom an average of  million false positive blood cultures are drawn in the us every year × thank you your message has been sent × is your target zero contact us now to discuss a zerorisk steripath evaluation for your hospital contact us for more information about magnolia medical and the steripath system please fill out the form below we will get in touch with you as soon as we can for more information about a zerorisk steripath evaluation complete the form below a representative with magnolia medical technologies will contact you within  hours   robert a gerberich  lebanon pa  intelius sign in we found robert a gerberich in lebanon pa robert a gerberich intelius found that robert a gerberich is a male between  and  years old from lebanon pa we have connected them to  addresses  phones and  relatives or associates also known as robert a smith get report now age robert a gerberich is in his s robert has lived in lebanon pa roberts relatives kate gerberich mary reich thomas gerberich samantha gerberich robert a gerberich zodiac signaries gendermale get report now want to know more about robert get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about robert or use our people search engine to find others get background check on robert a gerberich get a criminal check on robert a gerberich get a public record report on robert a gerberich get a people search report on robert a gerberich robert a gerberichs contact information known cities lived in find out where robert a gerberich has lived as well as robert a gerberichs phone numbers and email addresses robert a gerberich has lived in  states pennsylvania address for robert a gerberich  s  s lebanon pa has lived in lebanon pa get full address report phone numbers associated with robert a gerberich    lebanon pa    lebanon pa    lebanon pa get full phone report email addresses associated with robert a gerberich get email report robert a gerberichs social network and potential email matches find out potential social network profiles and potential email usernamed for robert a gerberich robert a gerberichs known social networks and potential email matches find all of robert a gerberichs social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches robert gerberich username matches robertgerberich gerberichrobert robertgerberich gerberichrobert robertgerberich gerberichrobert robertgerberich gerberichrobert rgerberich popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches r gerberich intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here robert edward gerberich  danville ca  intelius sign in we found robert edward gerberich in danville ca robert edward gerberich intelius found that robert edward gerberich is a male between  and  years old from danville ca we have connected them to  addresses  phones and  relatives or associates also known as bob gerberich get report now age robert edward gerberich is in his s robert has lived in danville ca hayward ca naperville il roberts relatives sean gerberich joanie gerberich kendall gerberich grace gerberich robert edward gerberich zodiac signgemini gendermale professional status president at ultrashape ltd get report now want to know more about robert get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about robert or use our people search engine to find others get background check on robert edward gerberich get a criminal check on robert edward gerberich get a public record report on robert edward gerberich get a people search report on robert edward gerberich robert edward gerberichs contact information known cities lived in find out where robert edward gerberich has lived as well as robert edward gerberichs phone numbers and email addresses robert edward gerberich has lived in  states california address for robert edward gerberich  l r danville ca has lived in danville ca hayward ca get full address report phone numbers associated with robert edward gerberich    danville ca    san ramon ca    naperville il get full phone report email addresses associated with robert edward gerberich rhcom bhcom get email report robert edward gerberichs professional information information regarding robert edward gerberichs professional history find out previous places robert edward gerberich has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act robert edward gerberich has worked at  place company ultrashape ltd title president robert edward gerberichs experience title president company ultrashape ltd job details company size less than  mil  employee range less than  additional professional information on robert edward gerberich see robert edward gerberichs linkedin profile robert edward gerberichs social network and potential email matches find out potential social network profiles and potential email usernamed for robert edward gerberich robert edward gerberichs known social networks and potential email matches find all of robert edward gerberichs social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches robert gerberich username matches robertgerberich gerberichrobert robertgerberich gerberichrobert robertgerberich gerberichrobert robertgerberich gerberichrobert rgerberich popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches r gerberich intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here magnolia medical appoints robert e gerberich as chief commercial officer magnolia medical appoints robert e gerberich as chief commercial officer new senior executive strengthens management team to accelerate commercialization of steripath blood collection system news provided by magnolia medical technologies apr    et share this article seattle april   prnewswire  magnolia medical technologies today announced the appointment of robert e gerberich as its chief commercial officer mr gerberich will be responsible for leading all commercial and customer facing functions of the company magnolia medical is a leading medical device company that develops manufactures and markets steripath® and other proprietary blood and bodily fluid collection devices that significantly improve the accuracy consistency and predictability of critical invitro diagnostic ivd tests mr gerberich is a global business leader with over  years of experience in the surgical and medical device segments of the life sciences market as a senior sales and marketing executive he has an exceptional track record of success building new markets and driving rapid commercial growth from product introduction through broad scale adoption most recently mr gerberich served as vice president of sales and marketing and vice president of sales at invuity inc under his direct commercial leadership invuity transformed from a small distributordriven surgical lighting startup into a rapid growth direct salesdriven advanced surgical photonics company leading the advancement of open minimal access surgery at invuity mr gerberich led the company from a  million up to  million revenue run rate delivering  consecutive quarters of quarteroverquarter sales growth additionally he drove the creation launch and implementation of strategic marketing and partnership programs that effectively facilitated a topdown bottomup sales strategy the commercial impact of these programs supported the successful initial public offering of the company in june of  prior to invuity mr gerberich served as president of ultrashape north america and head of global sales for ultrashape ltd acquired by syneron medical ltd where he established the north american subsidiary for ultrashape and launched the first nonsurgical focused ultrasound body sculpting technology in the world in these roles gerberich led corporate global sales and distribution in over  countries before ultrashape mr gerberich was vice president of sales and marketing and vice president of sales for thermage inc now solta medical a division of valeant pharmaceuticals where he led the startup business and successful platform launch of a proprietary radiofrequency technology creating a new market for noninvasive tissue tightening he built a direct sales organization from the ground up and led the company from  to a  million revenue run rate earlier in his career gerberich led dynamic and fast growing sales organizations at several other medical device companies that developed products for hospital markets we are thrilled to have bob join our senior management team and lead the overall commercial organization said greg bullington ceo of magnolia medical bobs unique background and demonstrated expertise seeding and rapidly developing new product categories and markets within the medical device industry make him the perfect fit based on our stage of growth he is an outstanding leader with an exceptional track record of success i am very enthusiastic to be joining magnolia medical technologies gerberich said our proprietary steripath blood culture collection system addresses a significant unmet clinical need and will set the new standard of care for the prevention of blood culture contamination and false positives throughout the world it is exciting to be with a company that has such a significant impact on improving patient care while yielding dramatic cost savings for the hospital and global healthcare markets about blood culture contamination blood culture is the essential blood test used to diagnose sepsis a complication from bloodstream infection that claims over  us lives each year and is a leading cause of death with the current use of traditional collection methods an average of  percent to  percent of positive blood culture tests are contaminated and ultimately determined to be false positive that original misdiagnosis in turn often exposes patients to potent antibiotic treatments that may be inappropriate as well as unnecessary and typically extends hospital length of stay with longer patient stays there is an increase in both healthcare costs and the risk of hospitalacquired conditions about steripath the companys proprietary flagship product steripath is the only blood collection system clinically proven to virtually eliminate the preventable error of blood culture contamination and false positive blood culture test results from patients with suspected sepsis the steripath blood collection system significantly reduces false positive results by diverting and sequestering the initial  milliliter of blood which can contain contaminants creating access for sterile blood flow into the culture test bottles the easy to use sterile singleuse closed system has been proven in multiple large scale clinical settings and trials to reduce false positive blood cultures by over  thereby reducing the unnecessary and inappropriate use of antibiotics and associated patient risks of developing antibioticresistant infections and complications and reduce the unnecessary costs and patient exposure to healthcareassociated infections hais associated with extended length of stay due to false positive culture results steripath facilitates immediate and measurable quality improvement for hospitals across the us that are implementing effective antimicrobial stewardship programs to reduce unnecessary and inappropriate use of antibiotics based on mandated requirements from the joint commission and cms about magnolia medical technologies magnolia medical is a medical device company that develops manufactures and markets innovative blood and bodily fluid collection devices that significantly improve the accuracy consistency and predictability of critical ivd tests false positive and false negative laboratory test results in the acute care setting create confusion and uncertainty that commonly lead to inappropriate unnecessary treatments these misdiagnoses often significantly increase utilization of antibiotics and associated complications as well as patient length of stay and risk for healthcareassociated infections hais by mechanically eliminating preventable errors that cause erroneous test results through elegantly engineered bodily fluid collection devices magnolia medicals products significantly improve patient safety patient experience and reduce hospital costs the company has amassed an extensive ip portfolio protecting its products including  issued method apparatus and design patents with over  additional patent applications pending the total potential market for magnolia medicals technology exceeds  billion annually for more information visit wwwmagnoliamedicalcom contact liz dowlingdowling  dennis public relationstel lizdowlingdennisnet   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesmagnoliamedicalappointsrobertegerberichaschiefcommercialofficerhtml source magnolia medical technologies apr    et preview magnolia medical announces additional funding of  million to expand use of steripath for sepsis blood testing my news release contains wide tables view fullscreen also from this source apr    et magnolia medical announces additional funding of  million to explore more news releases in similar topics health care  hospitals infection control medical equipment medical pharmaceuticals personnel announcements you just read magnolia medical appoints robert e gerberich as chief commercial officer news provided by magnolia medical technologies apr    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft magnolia medical appoints robert e gerberich as chief commercial officer  the business journals menu select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita limited time offer subscribe now search × close sign in sign in your account your account welcome your account sign in existing users create your free account dont have an account your account subscriptions newsletters custom notifications my custom site manage site users sign out sign in sign in your account search home industries  topics all industries  topics banking  financial services career  workplace commercial real estate education energy food  lifestyle government  regulations health care manufacturing media  marketing philanthropy  nonprofits professional services residential real estate retailing sports business technology transportation travel  tourism sponsored content cre now we value your business office environments small business marketing know your neighborhood news news latest news business pulse press releases lists  awards lists all lists build your own lists people  companies companies top private companies find businesses for sale search for company news people people on the move contact top executives executive profiles search for people in the news events events business event calendar nominations more… jobs find or post a job store subscriptions reprints  more how to grow your business advance your career thought leadership trends tips and insights from our partners subscribers manage your account about  contact about the business journals advertise help  faqs call center directory apps  syndication newsletters acbj publications bizwomen upstart hemmings sports business journal inside lacrosse bostinno dcinno chicagoinno austininno select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita follow us twitter linkedin facebook google  press releases magnolia medical appoints robert e gerberich as chief commercial officer new senior executive strengthens management team to accelerate commercialization of steripath blood collection system apr   am edt seattle april   prnewswire  magnolia medical technologies today announced the appointment of robert e gerberich as its chief commercial officer mr gerberich will be responsible for leading all commercial and customer facing functions of the company magnolia medical is a leading medical device company that develops manufactures and markets steripath® and other proprietary blood and bodily fluid collection devices that significantly improve the accuracy consistency and predictability of critical invitro diagnostic ivd tests mr gerberich is a global business leader with over  years of experience in the surgical and medical device segments of the life sciences market as a senior sales and marketing executive he has an exceptional track record of success building new markets and driving rapid commercial growth from product introduction through broad scale adoption most recently mr gerberich served as vice president of sales and marketing and vice president of sales at invuity inc under his direct commercial leadership invuity transformed from a small distributordriven surgical lighting startup into a rapid growth direct salesdriven advanced surgical photonics company leading the advancement of open minimal access surgery at invuity mr gerberich led the company from a  million up to  million revenue run rate delivering  consecutive quarters of quarteroverquarter sales growth additionally he drove the creation launch and implementation of strategic marketing and partnership programs that effectively facilitated a topdown bottomup sales strategy the commercial impact of these programs supported the successful initial public offering of the company in june of  prior to invuity mr gerberich served as president of ultrashape north america and head of global sales for ultrashape ltd acquired by syneron medical ltd where he established the north american subsidiary for ultrashape and launched the first nonsurgical focused ultrasound body sculpting technology in the world in these roles gerberich led corporate global sales and distribution in over  countries before ultrashape mr gerberich was vice president of sales and marketing and vice president of sales for thermage inc now solta medical a division of valeant pharmaceuticals where he led the startup business and successful platform launch of a proprietary radiofrequency technology creating a new market for noninvasive tissue tightening he built a direct sales organization from the ground up and led the company from  to a  million revenue run rate earlier in his career gerberich led dynamic and fast growing sales organizations at several other medical device companies that developed products for hospital markets we are thrilled to have bob join our senior management team and lead the overall commercial organization said greg bullington ceo of magnolia medical bobs unique background and demonstrated expertise seeding and rapidly developing new product categories and markets within the medical device industry make him the perfect fit based on our stage of growth he is an outstanding leader with an exceptional track record of success i am very enthusiastic to be joining magnolia medical technologies gerberich said our proprietary steripath blood culture collection system addresses a significant unmet clinical need and will set the new standard of care for the prevention of blood culture contamination and false positives throughout the world it is exciting to be with a company that has such a significant impact on improving patient care while yielding dramatic cost savings for the hospital and global healthcare markets about blood culture contamination blood culture is the essential blood test used to diagnose sepsis a complication from bloodstream infection that claims over  us lives each year and is a leading cause of death with the current use of traditional collection methods an average of  percent to  percent of positive blood culture tests are contaminated and ultimately determined to be false positive that original misdiagnosis in turn often exposes patients to potent antibiotic treatments that may be inappropriate as well as unnecessary and typically extends hospital length of stay with longer patient stays there is an increase in both healthcare costs and the risk of hospitalacquired conditions about steripath the companys proprietary flagship product steripath is the only blood collection system clinically proven to virtually eliminate the preventable error of blood culture contamination and false positive blood culture test results from patients with suspected sepsis the steripath blood collection system significantly reduces false positive results by diverting and sequestering the initial  milliliter of blood which can contain contaminants creating access for sterile blood flow into the culture test bottles the easy to use sterile singleuse closed system has been proven in multiple large scale clinical settings and trials to reduce false positive blood cultures by over  thereby reducing the unnecessary and inappropriate use of antibiotics and associated patient risks of developing antibioticresistant infections and complications and reduce the unnecessary costs and patient exposure to healthcareassociated infections hais associated with extended length of stay due to false positive culture results steripath facilitates immediate and measurable quality improvement for hospitals across the us that are implementing effective antimicrobial stewardship programs to reduce unnecessary and inappropriate use of antibiotics based on mandated requirements from the joint commission and cms about magnolia medical technologies magnolia medical is a medical device company that develops manufactures and markets innovative blood and bodily fluid collection devices that significantly improve the accuracy consistency and predictability of critical ivd tests false positive and false negative laboratory test results in the acute care setting create confusion and uncertainty that commonly lead to inappropriate unnecessary treatments these misdiagnoses often significantly increase utilization of antibiotics and associated complications as well as patient length of stay and risk for healthcareassociated infections hais by mechanically eliminating preventable errors that cause erroneous test results through elegantly engineered bodily fluid collection devices magnolia medicals products significantly improve patient safety patient experience and reduce hospital costs the company has amassed an extensive ip portfolio protecting its products including  issued method apparatus and design patents with over  additional patent applications pending the total potential market for magnolia medicals technology exceeds  billion annually for more information visit wwwmagnoliamedicalcom contact liz dowlingdowling  dennis public relationstel lizdowlingdennisnet   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesmagnoliamedicalappointsrobertegerberichaschiefcommercialofficerhtml source magnolia medical technologies the information on this page is provided by pr newswire all rights reserved reproduction or redistribution of this content without prior written consent from pr newswire is strictly prohibited is not responsible for this content learn more about this service about pr newswire the information on this page is provided by pr newswire the business journals is not responsible for this content learn more robert gerberich  chief commercial officer at magnolia medical technologies inc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink robert gerberich chief commercial officer at magnolia medical technologies inc overview in the news relationships paths education career history public holdings transactions robert gerberich chief commercial officer at magnolia medical technologies inc overview age  born  notable companies ultrashape na inc number of relationships this person is connected to  people in the news see more relsci april   robert gerberich is now serving in a new position at magnolia medical technologies inc pr newswire april   magnolia medical appoints robert e gerberich as chief commercial officer pr newswire september   springml delivers lighthouse for sales extending the power of salesforce wave analytics for sales managers operations and reps pr newswire february   invuity bolsters executive team adds industry veterans in key finance and commercial roles pr newswire february   invuity bolsters executive team adds industry veterans in key finance and commercial roles see full news coverage and complete stories with relsci professional create your news feed see more relationships see details douglas w heigel vice president operations at invuity inc gregory j bullington cofounder at magnolia medical technologies inc richard g patton cofounder at magnolia medical technologies inc philip m sawyer president  chief executive officer at invuity inc alex vayser former chief technology officer  cofounder at invuity inc jay schwartz vice president strategy  business development at magnolia medical technologies inc ward sparacio vice president sales  clinical operations at magnolia medical technologies inc brett m robertson chief executive officer at cureseq inc james h mackaness chief financial officer  principal accounting officer at invuity inc paul davison vice president research  development at invuity inc see  more listings with relsci professional start my free trial ➤ see  more paths to robert gerberich robert gerberich you connections via relationship science robert gerberich sync your contacts to see how you can connect with robert gerberich start my free trial ➤ see more educational background bs marketing sales administration  illinois state university illinois state university is illinois first public university founded in  at illinois state they devote their resources and energies to creating a supportive and productive campus community for all  students faculty staff alumni retirees contributors and visitors illinois state university is accredited by the higher learning commission of the north central association career history chief commercial officer   current magnolia medical technologies inc magnolia medical technologies inc develops medical devices that focus on improving the accuracy of diagnostic blood culture tests the company was founded by gregory j bullington and richard g patton and is headquartered in seattle wa vice president sales  marketing    invuity inc invuity inc is a medical technology company which engages in the development and market of surgical and medical devices its products include retractors handhelds and dropins under the photonics and photonblade brands the company was founded by kenneth b trauner and alex vayser on november   and is headquartered in san francisco ca senior vice president global sales  field development    primcogent solutions llc primcogent solutions llc manufactures and sells medical equipment the company is headquartered in dallas tx president    ultrashape na inc vice presidentmarketing  sales prior thermage inc thermage inc manufactures and distributes medical devices the company is developing innovative aesthetic technologies including its patented capacitive radiofrequency device to achieve a desired cosmetic or therapeutic effecton and under the skin surface the company was founded in the year  by edward w knowlton and is headquartered in hayward ca managernational sales prior inamed aesthetics region manager prior mentor corp mentor corp develops manufactures and markets sciencebased products it offers surgical and nonsurgical medical procedures such as breast implants skin and tissue expanders and facial and dermal implants the company was founded by christopher j conway in  and is headquartered in irvine ca region manager prior leibinger lp professional prior ultrashape ltd ultrashape redefines aesthetic medicine by developing manufacturing and marketing innovative noninvasive technologies for fat cell destruction and body sculpting the company develops and markets clinically proven safe and effective solutions that enhance the lives of patients the ultrashape proprietary technology employs pulsed nonthermal focused ultrasound that instantly selectively and permanently destroys fat cells without affecting surrounding structures founded in  ultrashape has sold contour i devices in more than  countries demonstrating safety and efficacythe ultrashape contour i system is authorized for marketing outside the us it is the first clinically proven noninvasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments the ultrashape system has been shown to be safe and effective in a multicenter controlled trial and numerous other peerreviewed published independent clinical studiesthe device is designed to produce mechanical nonthermal acoustic effects which target and selectively destroy breakdown fat cells leaving surrounding critical structures such as skin blood vessels nerves and connective tissue intact the latest contour i v system uses vertical dynamic focus™ vdf pulsed nonthermal focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive nodowntime solution to reduce localized fat deposits and body circumference the ultrashape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the bodys natural physiological and metabolic pathways these pathways are the same that handle fat during weight loss results from ultrashapes peerreviewed published multicenter controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liverover  patient treatments have been performed worldwide with the contour i showing high patient satisfaction while demonstrating safety and efficacy the ultrashape procedure is guided by proprietary realtime tracking and guidance technology designed to deliver smooth uniform body contouring results the software guides the operator through a presdetermined treatment algorithm designed to minimize risk of contour irregularities a common side effect of invasive and noninvasive procedures the ultrashape procedure is performed during a convenient walkin walkout session carried out in an officebased environment it requires no anesthesia or sedation after treatment patients immediately resume their daily routines with no need for maintenance treatmentsthe ultrashape contour i received the ce mark in  and a medical device license from health canada in  the contour i system is not available for sale in the us the contour plus system is an investigational product limited by us law to investigational use only public holdings restricted data only for relsci professional users start my free trial ➤ see more transactions details hidden invuity inc raised money in a private placement transaction details hidden invuity inc raised money in a private placement transaction other affiliations robert gerberich is affiliated with magnolia medical technologies inc invuity inc primcogent solutions llc ultrashape na inc thermage inc inamed aesthetics mentor corp leibinger lp ultrashape ltd youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ magnolia medical appoints robert e gerberich as chief commercial officerhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp  dow  nasdaq listenwho is the face of pro baseballyahoo finances dan roberts and myles udland debate the business of baseballmagnolia medical appoints robert e gerberich as chief commercial officerpr newswireapril  reblogsharetweetshareseattle april   prnewswire  magnolia medical technologies today announced the appointment of robert e gerberich as its chief commercial officer mr gerberich will be responsible for leading all commercial and customer facing functions of the company magnolia medical is a leading medical device company that develops manufactures and markets steripath® and other proprietary blood and bodily fluid collection devices that significantly improve the accuracy consistency and predictability of critical invitro diagnostic ivd testsmr gerberich is a global business leader with over  years of experience in the surgical and medical device segments of the life sciences market as a senior sales and marketing executive he has an exceptional track record of success building new markets and driving rapid commercial growth from product introduction through broad scale adoptionmost recently mr gerberich served as vice president of sales and marketing and vice president of sales at invuity inc under his direct commercial leadership invuity transformed from a small distributordriven surgical lighting startup into a rapid growth direct salesdriven advanced surgical photonics company leading the advancement of open minimal access surgeryat invuity mr gerberich led the company from a  million up to  million revenue run rate delivering  consecutive quarters of quarteroverquarter sales growth additionally he drove the creation launch and implementation of strategic marketing and partnership programs that effectively facilitated a topdown bottomup sales strategy the commercial impact of these programs supported the successful initial public offering of the company in june of prior to invuity mr gerberich served as president of ultrashape north america and head of global sales for ultrashape ltd acquired by syneron medical ltd where he established the north american subsidiary for ultrashape and launched the first nonsurgical focused ultrasound body sculpting technology in the world in these roles gerberich led corporate global sales and distribution in over  countriesbefore ultrashape mr gerberich was vice president of sales and marketing and vice president of sales for thermage inc now solta medical a division of valeant pharmaceuticals where he led the startup business and successful platform launch of a proprietary radiofrequency technology creating a new market for noninvasive tissue tightening he built a direct sales organization from the ground up and led the company from  to a  million revenue run rate earlier in his career gerberich led dynamic and fast growing sales organizations at several other medical device companies that developed products for hospital marketswe are thrilled to have bob join our senior management team and lead the overall commercial organization said greg bullington ceo of magnolia medical bobs unique background and demonstrated expertise seeding and rapidly developing new product categories and markets within the medical device industry make him the perfect fit based on our stage of growth he is an outstanding leader with an exceptional track record of successi am very enthusiastic to be joining magnolia medical technologies gerberich said our proprietary steripath blood culture collection system addresses a significant unmet clinical need and will set the new standard of care for the prevention of blood culture contamination and false positives throughout the world it is exciting to be with a company that has such a significant impact on improving patient care while yielding dramatic cost savings for the hospital and global healthcare marketsabout blood culture contaminationblood culture is the essential blood test used to diagnose sepsis a complication from bloodstream infection that claims over  us lives each year and is a leading cause of deathwith the current use of traditional collection methods an average of  percent to  percent of positive blood culture tests are contaminated and ultimately determined to be false positive that original misdiagnosis in turn often exposes patients to potent antibiotic treatments that may be inappropriate as well as unnecessary and typically extends hospital length of stay with longer patient stays there is an increase in both healthcare costs and the risk of hospitalacquired conditionsread moreabout steripaththe companys proprietary flagship product steripath is the only blood collection system clinically proven to virtually eliminate the preventable error of blood culture contamination and false positive blood culture test results from patients with suspected sepsisthe steripath blood collection system significantly reduces false positive results by diverting and sequestering the initial  milliliter of blood which can contain contaminants creating access for sterile blood flow into the culture test bottlesthe easy to use sterile singleuse closed system has been proven in multiple large scale clinical settings and trials to reduce false positive blood cultures by over  thereby reducing the unnecessary and inappropriate use of antibiotics and associated patient risks of developing antibioticresistant infections and complications and reduce the unnecessary costs and patient exposure to healthcareassociated infections hais associated with extended length of stay due to false positive culture resultssteripath facilitates immediate and measurable quality improvement for hospitals across the us that are implementing effective antimicrobial stewardship programs to reduce unnecessary and inappropriate use of antibiotics based on mandated requirements from the joint commission and cmsabout magnolia medical technologiesmagnolia medical is a medical device company that develops manufactures and markets innovative blood and bodily fluid collection devices that significantly improve the accuracy consistency and predictability of critical ivd tests false positive and false negative laboratory test results in the acute care setting create confusion and uncertainty that commonly lead to inappropriate unnecessary treatments these misdiagnoses often significantly increase utilization of antibiotics and associated complications as well as patient length of stay and risk for healthcareassociated infections hais by mechanically eliminating preventable errors that cause erroneous test results through elegantly engineered bodily fluid collection devices magnolia medicals products significantly improve patient safety patient experience and reduce hospital costs the company has amassed an extensive ip portfolio protecting its products including  issued method apparatus and design patents with over  additional patent applications pending the total potential market for magnolia medicals technology exceeds  billion annually for more information visit wwwmagnoliamedicalcomcontact liz dowling dowling  dennis public relations tel  lizdowlingdennisnet to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesmagnoliamedicalappointsrobertegerberichaschiefcommercialofficerhtmlreblogsharetweetsharerecently viewedyour list is emptywhat to read nextslimy slugs inspire potentially lifesaving medical gluebbc newsengineer finds pattern makes millions in stocksmoney morningsponsoredtrump to cops please dont be too nice while arresting thugs and dont worry about their heads when you toss them in the paddy wagonbusiness insiderthe two pizza rule is a secret to productive meetings that helped amazon ceo jeff bezos become one of the worlds richest menbusiness insiderhere are the us targets north korea most likely wants to nukebusiness insiderhuman barbie takes off make up drs are speechlesskiwi reportsponsoredchevron and exxon mobil have a tough path ahead nyse traderyahoo finance videostocks mixed after heavy earnings weektrump names john f kelly new chief of staff reince priebus outcnbcwhats the problem with joel osteenchurchleaderscomsponsoredthe real reason overseas manufacturing is coming to americayahoo financea major player in the struggle for control of the sinaloa cartel just surrendered in the usbusiness insidermy bullish view on stocks hasnt changed one iota nyse traderyahoo finance video mustown stocks in banyan hillsponsoredblue apron bullish calls not all theyre cooked up to beyahoo financenorth korea nd icbm test puts much of us in range expertsassociated pressstruggling to govern trump faces growing republican uneasestuart actually this is the best our country can do right now if the republicans accomplished anything it would be tax cuts for the wealthy cuts to medicaid medicare and social security removal of all banking regulations and environmental protections and on and on get rid of these traitors in  so our country can be great againjoin the conversation